5 hrs ago | Med Ad News
Sun Pharma announces USFDA approval for generic Casodex tablets
Mumbai, July 7, 2009: Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for an Abbreviated New Drug Application for generic Casodex , bicalutamide tablets.
Mylan Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex
Mylan Inc. has announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the FDA for its Abbreviated New Drug Application for Bicalutamide Tablets, 50 mg.
Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Casodex(R) Tablets
Companies mentioned in this article: Caraco Pharmaceutical Laboratories, Ltd. DETROIT , /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd.
Medivation Announces Positive New Efficacy Data From Phase 1-2 Trial...
Findings Presented at American Society of Clinical Oncology 2009 Annual Meeting and Included in Best of ASCO Educational Program -- SAN FRANCISCO, June 2 /PRNewswire-FirstCall/ -- Medivation, Inc.
New Drug Shows Promise In Treating Drug-Resistant Prostate Cancer
Main Category: Prostate / Prostate Cancer Also Included In: MRSA / Drug Resistance Biology / Biochemistry A new therapy for metastatic prostate cancer has shown considerable promise in early clinical trials involving patients whose disease has become resistant to current drugs.
New drug shows promise in treating drug-resistant prostate cancer
A new therapy for metastatic prostate cancer has shown considerable promise in early clinical trials involving patients whose disease has become resistant to current drugs.
Medivation, Inc. Prostate Drug Shows Promise-Study
Medivation, Inc. today announced publication of an article in the April 9, 2009, issue of Science Express, the online version of the journal Science, presenting the discovery and novel mechanism of action of MDV3100, the Company's androgen receptor antagonist drug candidate.
New medications show promise in treating drug-resistant prostate cancer
A new therapy for metastatic prostate cancer has shown considerable promise in early clinical trials involving patients whose disease has become resistant to current drugs.
Genome-Wide Impact of Androgen Receptor Trapped clone-27 Loss on...
DevilInPgh Abstract The androgen receptor directs diverse biological processes through interaction with coregulators such as AR trapped clone-27 . Our results show that ART-27 is recruited to AR-binding sites by chromatin immunoprecipitation analysis.
Selection for Androgen Receptor Mutations in Prostate Cancers Treated with Androgen Antagonist
Mutations were found in 5 of 16 patients who received combined androgen blockade with the AR antagonist flutamide, and these mutant ARs were strongly stimulated by flutamide.
Aberrant Activation Of Androgen Receptor In A New...
UroToday.com - In the January 2009 issue of Cancer Research , Dr. Joy Yang and colleagues reported a new animal model of neuropeptide mediated prostate cancer .
Research and Markets: Get the Latest on Prostate Cancer: Drug Pipeline Update 2009
Research and Markets has announced the addition of the "Prostate Cancer: Drug Pipeline Update 2009" report to their offering.
Thousands 'have taken fake drugs'
Thirty-thousand packs of fake life-saving drugs may have been consumed by NHS patients, the BBC has learned.
Androgen metabolism in adipose tissue: Recent advances.
FW_Gibb Abstract Androgens modulate adipocyte function and affect the size of adipose tissue compartments in humans.